G&E Herbal Biotechnology Co., Ltd. (TPEX:4911)

G&E Herbal Biotechnology Ratios and Metrics

Market cap in millions TWD. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 4, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	3,043	3,339	3,440	2,972	1,558	1,940
Market Cap Growth	-9.05%	-2.92%	15.73%	90.71%	-19.66%	-3.19%
Enterprise Value	2,632	3,017	3,226	2,849	1,446	1,819
Last Close Price	47.75	51.65	52.67	45.51	23.86	29.70
PE Ratio	21.30	32.72	47.51	402.69	-	-
PS Ratio	9.76	13.41	18.96	46.01	63.43	68.71
PB Ratio	3.38	4.01	4.51	4.30	2.28	2.76
P/TBV Ratio	3.96	4.77	5.47	5.34	2.84	3.42
P/FCF Ratio	18.37	25.94	31.86	30.64	-	-
P/OCF Ratio	17.91	24.80	30.31	29.73	-	2515.89
EV/Sales Ratio	8.44	12.12	17.78	44.10	58.83	64.44
EV/EBITDA Ratio	15.66	23.35	35.88	191.43	-	-
EV/EBIT Ratio	16.70	25.22	39.98	519.39	-	-
EV/FCF Ratio	15.89	23.44	29.88	29.37	-	-
Debt / Equity Ratio	0.00	0.00	0.00	-	-	-
Debt / EBITDA Ratio	0.01	0.01	0.02	-	-	-
Debt / FCF Ratio	0.01	0.01	0.02	-	-	-
Asset Turnover	-	0.27	0.22	0.09	0.04	0.04
Inventory Turnover	-	1.96	1.55	1.14	0.81	1.07
Quick Ratio	6.61	3.42	2.77	2.25	13.14	15.04
Current Ratio	7.00	3.61	2.97	2.54	15.66	17.42
Return on Equity (ROE)	-	12.78%	9.96%	1.07%	-2.87%	-2.01%
Return on Assets (ROA)	-	8.12%	6.05%	0.46%	-1.74%	-1.34%
Return on Capital (ROIC)	-	9.34%	6.93%	0.50%	-1.76%	-1.36%
Return on Capital Employed (ROCE)	17.50%	14.30%	10.60%	0.80%	-2.90%	-2.20%
Earnings Yield	4.70%	3.06%	2.10%	0.25%	-1.28%	-0.74%
FCF Yield	5.44%	3.86%	3.14%	3.26%	-0.70%	-0.22%
Dividend Yield	1.47%	1.36%	0.95%	-	-	-
Payout Ratio	31.21%	31.12%	-	-	-	-
Buyback Yield / Dilution	-0.05%	-0.06%	-0.08%	-	-	-
Total Shareholder Return	1.41%	1.30%	0.86%	-	-	-

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.